4-Dimethylaminobenzoate → N-(1-(4-Amino-2-fluorophenyl)-1H-indazol-5-yl)-4-dimethylaminobenzamide
Reaktionsgleichung
[NH2:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[N:7]([C:11]1[CH:16]=[CH:15][C:14]([NH2:17])=[CH:13][C:12]=1[F:18])[N:6]=[CH:5]2.[CH3:19][N:20]([CH3:30])[C:21]1[CH:29]=[CH:28][C:24]([C:25]([O-])=[O:26])=[CH:23][CH:22]=1>>[NH2:17][C:14]1[CH:15]=[CH:16][C:11]([N:7]2[C:8]3[C:4](=[CH:3][C:2]([NH:1][C:25](=[O:26])[C:24]4[CH:23]=[CH:22][C:21]([N:20]([CH3:19])[CH3:30])=[CH:29][CH:28]=4)=[CH:10][CH:9]=3)[CH:5]=[N:6]2)=[C:12]([F:18])[CH:13]=1Komponenten
3
Versuchsvorschrift
Compound 388 was prepared according to the procedure described in Scheme IV from 5-amino-1-(4-amino-2-fluorophenyl)indazole and 4-dimethylaminobenzoate. [M+H]+ calcd for C22H20FN5O: 390.17; found: 389.96.
Quellen und Nachweise
- ORD-Eintrag
- ord-1bfd5cc32c3c4180b4e5d52984b08c51
- Quelldatensatz
- uspto-grants-2015_09